Key facts
- This page summarizes Andrew J. Armanino's Form 4 filing for Better Therapeutics, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 20 Dec 2023, 17:22.
Andrew J. Armanino - 18 Dec 2023 Form 4 Insider Report for Better Therapeutics, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 18 Dec 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 Dec 2023, 17:22:11 UTC
- Prior SEC filing
- 02 Nov 2023
- Next SEC filing
- 05 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Leslie Miller, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Andrew J. Armanino filed Form 4 for Better Therapeutics, Inc. on 20 Dec 2023.
Change
- Previous filing in this sequence was filed on 02 Nov 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BTTX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +3,750
- Change %
- +28%
- Price
- $0.000000
- Shares after
- 17,084
- Date
- 18 Dec 2023
- Ownership
- Direct
- Footnotes
- F1
BTTX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 728,368
- Date
- 18 Dec 2023
- Ownership
- By Armanino Trust
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The Reporting person was awarded 3,750 Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on June 1, 2024.
Footnote F2
These shares are owned directly by the Andrew J. Armanino III and Denise M. Armanino Family Trust (the "Armanino Trust", and directly by the Reporting Person and his spouse, Denise M. Armanino, as trustees of the Armanino Trust.